Detalles de la búsqueda
1.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(7): 919-930, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690073
2.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Lancet
; 394(10214): 2084-2095, 2019 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791688
3.
Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre.
BMC Cancer
; 20(1): 53, 2020 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31964373
4.
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Lancet Oncol
; 19(12): 1680-1687, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30413383
5.
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial.
Lancet Oncol
; 14(3): 236-43, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23333117
6.
The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy.
Oncotarget
; 7(30): 47927-47937, 2016 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27323818
7.
Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist.
Eur J Cancer
; 60: 40-8, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27062316
8.
Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer.
J Clin Oncol
; 29(28): 3798-804, 2011 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21859991
Resultados
1 -
8
de 8
1
Próxima >
>>